Mereo BioPharma Group
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Cavendish Pl Fl 4, London, Greater Lon...Phone Number
+44 3330237300Website
www.mereobiopharma.comRevenue
<$5 MillionStock Symbol
MREOIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Mereo BioPharma Group
Mereo is a biopharmaceutical company focused on the development and commercialisation of innovative therapeutics that aim to improve outcomes for patients with rare diseases. Mereo's strategy is to selectively acquire product candidates that have already received significant investment from pharmaceutical companies and that have substantial preclinical, clinical and manufacturing data packages. In December 2018, Mereo announced the proposed combination of Mereo and OncoMed Pharmaceuticals, with the transaction expected to close in the second quarter of 2019. Each of Mereo's four product candidates has previously generated positive clinical data for Mereo's target indication or in a related indication.Explore more
Mereo BioPharma Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mereo BioPharma Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Mereo BioPharma Group launches new products
Check out if Mereo BioPharma Group is spiking on competitors!
Check if Mereo BioPharma Group has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Mereo BioPharma Group recently announced quarterly report
Mereo BioPharma Group, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Mereo BioPharma Group
Funding: Get notified immidiatlly once Mereo BioPharma Group has new funding data
Click to see if Mereo BioPharma Group had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Mereo BioPharma Group as Masked Content
Find 2 more new buyers
Compare Similar Companies to Mereo BioPharma Group
Compare insights from companies similar to Mereo BioPharma Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mereo BioPharma Group
<$5M
11-50
Public
$5M
2015
WF
William FeelySenior Director & Head of Clinical Development & Operations
Company Profile Activity
Activity Insights
Mereo BioPharma Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mereo BioPharma Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mereo BioPharma Group.
Mereo BioPharma Group financials insights
Gather financial insights about Mereo BioPharma Group, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Private Equity
$5M
Mereo BioPharma Group Tech Stack
A closer look at the technologies used by Mereo BioPharma Group
Most Recent Scoops
Pain Point
Pain Point, Lawsuits, Legal Affairs, Medical Research, Pharmaceuticals
Open Position
Person-Based
Earnings
Business Development
Earnings
Sales
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mereo BioPharma Group
Sign Up For FreeTo access detailed company insights
Mereo is a biopharmaceutical company focused on the development and commercialisation of innovative therapeutics that aim to improve outcomes for patients with rare diseases. Mereo's strategy is to selectively acquire product candidates that have already received significant investment from pharmaceutical companies and that have substantial preclin... Read More
